These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 3338092)

  • 21. Analysis of a murine anti-ganglioside GD2 monoclonal antibody expressing both IgG2a and IgG3 isotypes: monoclonality, apoptosis triggering, and activation of cellular cytotoxicity on human melanoma cells.
    Lin CC; Shen YC; Chuang CK; Liao SK
    Adv Exp Med Biol; 2001; 491():419-29. PubMed ID: 14533812
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coordinator's report: an assessment of the functional activity of human Rh monoclonal antibodies after their evaluation by nine laboratories.
    Kumpel BM
    Transfus Clin Biol; 1996; 3(6):439-52. PubMed ID: 9018805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimeric B72.3 mouse/human (IgG1) antibody directs the lysis of tumor cells by lymphokine-activated killer cells.
    Primus FJ; Pendurthi TK; Hutzell P; Kashmiri S; Slavin DC; Callahan R; Schlom J
    Cancer Immunol Immunother; 1990; 31(6):349-57. PubMed ID: 2386980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Importance of immunoglobulin isotype in human antibody-dependent, cell-mediated cytotoxicity directed by murine monoclonal antibodies.
    Kipps TJ; Parham P; Punt J; Herzenberg LA
    J Exp Med; 1985 Jan; 161(1):1-17. PubMed ID: 3918141
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.
    Akiyama Y; Lubeck MD; Steplewski Z; Koprowski H
    Cancer Res; 1984 Nov; 44(11):5127-31. PubMed ID: 6435864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody-dependent antitumor cytotoxicity by human monocytes cultured with recombinant macrophage colony-stimulating factor. Induction of efficient antibody-mediated antitumor cytotoxicity not detected by isotope release assays.
    Munn DH; Cheung NK
    J Exp Med; 1989 Aug; 170(2):511-26. PubMed ID: 2526848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surface receptors and immune activity of purified human circulating mononuclear cells. III. The mechanisms of lysis, by lymphocytes and monocytes, of target cells in the lymphocyte-dependent and monocyte-dependent ADCC, NK, NOCC, and MICC cytotoxic reactions.
    Richter M; Kazaniwsky N
    Cell Immunol; 1987 Sep; 108(2):297-312. PubMed ID: 3621351
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD8+ T cells lyse autologous monocytes in the presence of anti-CD3 monoclonal antibody: association with interleukin-1 production.
    Itoh K; Balch CM; Trial J; Platsoucas CD
    Cell Immunol; 1988 Jul; 114(2):257-71. PubMed ID: 3260540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural killer (NK) cells as effectors of antibody-dependent cytotoxicity with chimeric antibodies reactive with human squamous-cell carcinomas of the head and neck.
    Sung MW; Yasumura S; Johnson JT; Van Dongen GA; Whiteside TL
    Int J Cancer; 1995 Jun; 61(6):864-72. PubMed ID: 7790123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An Fc engineering approach that modulates antibody-dependent cytokine release without altering cell-killing functions.
    Kinder M; Greenplate AR; Strohl WR; Jordan RE; Brezski RJ
    MAbs; 2015; 7(3):494-504. PubMed ID: 25933349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological activity of human-mouse IgG1, IgG2, IgG3, and IgG4 chimeric monoclonal antibodies with antitumor specificity.
    Steplewski Z; Sun LK; Shearman CW; Ghrayeb J; Daddona P; Koprowski H
    Proc Natl Acad Sci U S A; 1988 Jul; 85(13):4852-6. PubMed ID: 3387441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human anti-CAIX antibodies mediate immune cell inhibition of renal cell carcinoma in vitro and in a humanized mouse model in vivo.
    Chang DK; Moniz RJ; Xu Z; Sun J; Signoretti S; Zhu Q; Marasco WA
    Mol Cancer; 2015 Jun; 14():119. PubMed ID: 26062742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human large granular lymphocytes express high affinity receptors for murine monoclonal antibodies of the IgG3 subclass.
    Anasetti C; Martin PJ; Morishita Y; Badger CC; Bernstein ID; Hansen JA
    J Immunol; 1987 May; 138(9):2979-81. PubMed ID: 2952730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prestimulation of monocytes by the cytokines GM-CSF or IL-2 enhances the antibody dependent cellular cytotoxicity of monoclonal antibody 17-1A.
    Flieger D; Spengler U; Beier I; Sauerbruch T; Schmidt-Wolf IG
    Z Gastroenterol; 2000 Aug; 38(8):615-22. PubMed ID: 11031784
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synergistic antitumor effects of BCG and monoclonal antibodies capable of inducing antibody-dependent cell-mediated cytotoxicity.
    Komuta K; Kawase I; Ogura T; Masuno T; Yokota S; Hosoe S; Ikeda T; Shirasaka T; Kishimoto S
    Jpn J Cancer Res; 1987 Feb; 78(2):185-92. PubMed ID: 3104261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effector cell analysis of human multidrug-resistant cell killing by mouse-human chimeric antibody against P-glycoprotein.
    Nishioka Y; Sone S; Heike Y; Hamada H; Ariyoshi K; Tsuruo T; Ogura T
    Jpn J Cancer Res; 1992 Jun; 83(6):644-9. PubMed ID: 1353755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of antibody isotype in monoclonal anti-idiotype therapy of a murine B cell lymphoma. A study of hybridoma class switch variants.
    Kaminski MS; Kitamura K; Maloney DG; Campbell MJ; Levy R
    J Immunol; 1986 Feb; 136(3):1123-30. PubMed ID: 3484499
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-CD105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-GD2 Antibody Immunotherapy of Neuroblastoma with Activated Natural Killer Cells.
    Wu HW; Sheard MA; Malvar J; Fernandez GE; DeClerck YA; Blavier L; Shimada H; Theuer CP; Sposto R; Seeger RC
    Clin Cancer Res; 2019 Aug; 25(15):4761-4774. PubMed ID: 31068371
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of antigen density and antibody affinity on antibody-dependent cellular cytotoxicity: relevance for immunotherapy of carcinomas.
    Velders MP; van Rhijn CM; Oskam E; Fleuren GJ; Warnaar SO; Litvinov SV
    Br J Cancer; 1998 Aug; 78(4):478-83. PubMed ID: 9716030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement and cellular cytotoxicity in antibody therapy of cancer.
    Wang SY; Weiner G
    Expert Opin Biol Ther; 2008 Jun; 8(6):759-68. PubMed ID: 18476787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.